期刊文献+

Peroxiredoxin Ⅲ在大鼠超负荷心肌肥厚过程中的表达变化 被引量:2

Change of peroxiredoxin Ⅲ mRNA expression in process of rats pressure-overload cardiac hypertrophy
下载PDF
导出
摘要 目的:探讨Peroxiredoxin Ⅲ(PrxⅢ)在大鼠超负荷心肌肥厚过程中的表达变化。方法:雄性SD大鼠随机分为假手术对照组和模型组,模型组大鼠实施腹主动脉缩窄术,制备压力超负荷心肌肥厚模型。分别于术后24h,2、4、6周,测定血液动力学变化;称量心体质量;光镜和电子显微镜观察左心室的组织变化;提取左心室RNA,RT-PCR分析PrxⅢ的表达变化。结果:术后24h两组大鼠的血液动力学和心肌形态无明显变化。术后2、4、6周时,模型组大鼠的SBP、DBP、LVSP、LVED及左心室体质量指数逐渐增加,心肌纤维逐渐增粗,线粒体逐渐增多,肌节增长。术后24h PrxⅢ的表达稍有降低,但无统计学意义,2周时则明显降低,4周有所上升但仍低于对照,6周时明显上升且高于对照组。结论:PrxⅢ mRNA表达呈现先降低后增高的趋势,即在心肌肥厚中早期表达降低,而在心肌肥厚形成后表达明显升高,表明PrxⅢ参与了超负荷心肌肥厚的发生。 Objective: To investigate the expression change of peroxiredoxin Ⅲ(PrxⅢ) in process of rats overload cardiac hypertrophy. Methods: Male SD rats were divided randomly into a shame operation control group and a model group. Cardiac hypertrophy model was made through partial ligation of the abdominal aorta. After 24 h, 2 weeks, 4 weeks, 6 weeks of operation, physiological index was first detected, then left ventricle was observed under light and electron microscopes and PrxⅢ mRNA expression was measured. Results: Model of rat cardiac hypertrophy was formed on 6 weeks after operation through analyzing the change of the physiological index and morphology. Compared to the control group, the expression of PrxⅢ mRNA was lowered on 24 h and further lowered on 2 weeks. PrxⅢ mRNA began to enhance but was still lower than that of control on 4 weeks; On 6 weeks, PrxⅢ mRNA was significantly higher than that of the control group. Conclusion: The expression of PrxⅢ first decreased and then increased during the process of rat pressure-overload cardiac hypertrophy. PrxⅢ may take part in the forming and development of pressure-overload cardiac hypertrophy.
出处 《解剖学杂志》 CAS CSCD 北大核心 2009年第3期322-325,共4页 Chinese Journal of Anatomy
基金 国家自然科学基金(30500200) 河北省教育厅科研基金(037)
关键词 PEROXIREDOXIN 心肌肥厚模型 活性氧族 氧化应激 peroxiredoxin Ⅲ cardiac hypertrophy model reactive oxygen species oxidative stress
  • 相关文献

参考文献2

二级参考文献32

  • 1Halliwell B. Antioxidants in human health and disease. Annu Rev Nutr 1996; 16: 33-50.
  • 2Willcox JK, Ash SL, Catignani GL. Antioxidants and prevention of chronic disease. Crit Rev Food Sci Nutr 2004; 44: 275-95.
  • 3Berg D, Youdim MB, Riederer P. Redox imbalance. Cell Tissue Res 2004; 318: 201-13.
  • 4Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Nicolaides DN. Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities. Curr Pharm Des 2004; 10: 3813-33.
  • 5Voora D, McLeod HL, Eby C, Gage BF. The pharmacogenetics of coumarin therapy. Pharmacogenomics 2005; 6: 503-13.
  • 6Lin HC, Tsai SH, Chen CS, Chang YC, Lee CM, Lai ZY, et al. Structure-activity relationship of coumarin derivatives on xanthine oxidase-inhibiting and free radical-scavenging activities. Biochem Pharmacol 2008; 75: 1416-25.
  • 7Lin WL, Wang CJ, Tsai YY, Liu CL, Hwang JM, Tseng TH. Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver. Arch Toxicol 2000; 74: 467-72.
  • 8Joyeux M, Lobstein A, Anton R, Mortier F. Comparative antilipoperoxidant, antinecrotic and scavenging properties of terpenes and biflavones from Ginkgo and some flavonoids. Planta Med 1995; 61: 126-9.
  • 9Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996; 20: 933-56.
  • 10Lo SF, Nalawade SM, Mulabagal V, Matthew S, Chen CL, Kuo CL, et al. In vitro propagation by asymbiotic seed germination and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity studies of tissue culture raised plants of three medicinally important species of Dendrobium. Biol Pharm Bull 2004; 27: 731-5.

共引文献5

同被引文献7

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部